Jefferies Initiates Coverage On Pacific Biosciences With Buy Rating, Announces Price Target of $4
Jefferies Initiates Coverage On Pacific Biosciences With Buy Rating, Announces Price Target of $4
Jefferies以買入評級開始對Pacific Biosciences進行覆蓋，宣佈目標價格為$4。
Jefferies analyst Tycho Peterson initiates coverage on Pacific Biosciences (NASDAQ:PACB) with a Buy rating and announces Price Target of $4.
Jefferies分析師Tycho Peterson開始對Pacific Biosciences（納斯達克代碼：PACB）進行覆蓋，給出買入評級並宣佈4美元的目標價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。